RA
CPIX icon

Royce & Associates’s Cumberland Pharmaceuticals CPIX Stock Holding History

Royce & Associates’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,600
Closed -$84K – 1131
2015
Q3 		$84K Hold
14,600
– – ﹤0.01% 1134
2015
Q2 		$104K Buy
14,600
+2,900
+25% +$20.2K ﹤0.01% 1151
2015
Q1 		$78K Buy
+11,700
New +$73K ﹤0.01% 1172

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royce & Associates's CPIX Position: Q4 2015 in Review

Royce & Associates sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2015, closing a stake of 14,600 shares — an estimated $84K sold.

Royce & Associates first reported a position in CPIX in Q1 2015 and held it in 3 quarters. The position peaked at $104K in Q2 2015. 47 funds tracked by Wall St. Rank hold CPIX as of Q4 2015.

  • Royce & Associates reported no remaining Cumberland Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Royce & Associates sold 14,600 Cumberland Pharmaceuticals shares in Q4 2015, an estimated $84K.
  • Royce & Associates first reported a position in Cumberland Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Royce & Associates's Cumberland Pharmaceuticals position peaked at $104K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2015.

Based on Royce & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.